AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Lidocaine for LESS Postoperative Shoulder Pain Alleviation

RecruitingNAAges 18 Years - 65 YearsFemalePeking Union Medical College Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Objective: To evaluate the efficacy of subdiaphragmatic spray of 0.08% lidocaine in relieving postoperative acute pain and psychological status of patients undergoing single-port laparoscopic surgery for benign gynecological diseases, and to provide evidence-based basis for optimizing postoperative analgesic strategies. Methods: A single-center, prospective randomized controlled study was conducted. A total of 100 patients scheduled for elective single-port laparoscopic surgery due to uterine fibroids, ovarian cysts, or other benign gynecological conditions were selected from the General Gynecology Center of Peking Union Medical College Hospital. They were divided into the experimental group (n=50) and the control group (n=50) using a random number table. The experimental group received 50 ml of 0.08% lidocaine solution sprayed on the bilateral subdiaphragmatic regions at the start of s

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age: Female patients aged 18-65 years; * Clear preoperative diagnosis, suitable for single-port laparoscopic surgery, and American Society of Anesthesiologists (ASA) physical status classification I-II; * Patients or their family members can understand the study protocol, are willing to participate in the study, and provide written informed consent. Exclusion Criteria: * Allergy to lidocaine or amide-type local anesthetics; * Severe medical comorbidities; * Long-term preoperative use of opioid drugs or sedatives; * Pregnant or lactating women; * Conversion to laparotomy or addition of surgical ports during surgery.
๐Ÿ’Š

What it tests

  • subdiaphragmatic lidocaine sprayed
  • standard ERAS
๐Ÿ“

Where

1 site
Peking Union Medical College
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy